Daily oral grepafloxacin vs. twice daily oral doxycycline in the treatment of Chlamydia trachomatis endocervical infection

Clicks: 395
ID: 115364
1998
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Seven days of treatment with oral grepafloxacin, 400 mg once daily, was as effective as 7 days of treatment with oral doxycycline, 100 mg twice daily, in patients with cervicitis caused by C. trachomatis. Both agents were well tolerated and had comparable safety profiles. Grepafloxacin's once-daily …
Reference Key
wm1998infectiousdaily Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors McCormack WM;Martin DH;Hook EW;Jones RB;;
Journal infectious diseases in obstetrics and gynecology
Year 1998
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9785106
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine treatment outcome adult female adolescent middle aged Drug Administration Schedule Comparative Study Clinical Trial Randomized Controlled Trial Double-Blind Method anti-bacterial agents / administration & dosage* anti-infective agents / administration & dosage* fluoroquinolones* oral chlamydia infections / drug therapy* w m mccormack uterine cervicitis / drug therapy* uterine cervicitis / microbiology chlamydia trachomatis / isolation & purification doxycycline / administration & dosage* pmid:9785106 pmc1784789 doi:10.1002/(sici)1098-0997(1998)6:33.0.co;2-s d h martin r b jones chlamydia trachomatis / drug effects* piperazines / administration & dosage* quinolones / administration & dosage*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.